Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

The US Patent and Trademark Office (USPTO) has granted a patent to Genprex for the use of its Reqorsa gene therapy ...

Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...

At two upcoming events, experts will offer practical solutions to key challenges for oncology and rare disease clinical ...

In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of capital.